Table of Contents Author Guidelines Submit a Manuscript
Pulmonary Medicine
Volume 2012, Article ID 657180, 7 pages
http://dx.doi.org/10.1155/2012/657180
Clinical Study

Do We Need Exercise Tests to Detect Gas Exchange Impairment in Fibrotic Idiopathic Interstitial Pneumonias?

1Clinique des Maladies Respiratoires, Centre de Compétence des Maladies Pulmonaires Rares, Hopital Calmette, Lille 2 University Boulevard Leclercq, CHRU, 59037 Lille, France
2Unité de Biostatistiques, CHRU, 59037 Lille, France
3Service d'Explorations Fonctionnelles Respiratoires, Hopital Calmette, CHRU, 59037 Lille, France

Received 24 March 2012; Accepted 14 May 2012

Academic Editor: Marc A. Judson

Copyright © 2012 Benoit Wallaert et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. American Thoracic Society and European Respiratory Society, “American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee,” American Journal of Respiratory and Critical Care Medicine, vol. 165, no. 2, pp. 277–304, 2002. View at Google Scholar
  2. American Thoracic Society, “Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS),” American Journal of Respiratory and Critical Care Medicine, vol. 161, no. 2, part 1, pp. 646–664, 2000. View at Google Scholar
  3. B. Bradley, H. M. Branley, and J. J. Egan, “Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society,” Thorax, vol. 63, no. 5, pp. v1–v58, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Raghu, H. R. Collard, J. J. Egan et al., “An Official ATS/ERS/JRS/ALAT Statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management,” American Journal of Respiratory and Critical Care Medicine, vol. 183, no. 6, pp. 788–824, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. A. L. Katzenstein, “Idiopathic interstitial pneumonia: classification and diagnosis,” Monographs in Pathology, pp. 1–31, 1993. View at Google Scholar · View at Scopus
  6. J. D. Fulmer, W. C. Roberts, E. R. von Gal, and R. G. Crystal, “Morphologic-physiologic correlates of the severity of fibrosis and degree of cellularity in idiopathic pulmonary fibrosis,” Journal of Clinical Investigation, vol. 63, no. 4, pp. 665–676, 1979. View at Google Scholar · View at Scopus
  7. J. J. Egan, F. J. Martinez, A. U. Wells, and T. Williams, “Lung function estimates in idiopathic pulmonary fibrosis: the potential for a simple classification,” Thorax, vol. 60, no. 4, pp. 270–273, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. A. G. N. Agusti, J. Roca, J. Gea, P. D. Wagner, A. Xaubet, and R. Rodriguez-Roisin, “Mechanisms of gas-exchange impairment in idiopathic pulmonary fibrosis,” American Review of Respiratory Disease, vol. 143, no. 2, pp. 219–225, 1991. View at Google Scholar · View at Scopus
  9. C. Risk, G. R. Epler, and E. A. Gaensler, “Exercise alveolar-arterial oxygen pressure difference in interstitial lung disease,” Chest, vol. 85, no. 1, pp. 69–74, 1984. View at Google Scholar · View at Scopus
  10. T. S. Hallstrand, L. J. Boitano, W. C. Johnson, C. A. Spada, J. G. Hayes, and G. Raghu, “The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis,” European Respiratory Journal, vol. 25, no. 1, pp. 96–103, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Agusti, A. Xaubet, A. G. N. Agusti, J. Roca, J. Ramirez, and R. Rodriguez-Roisin, “Clinical and functional assessment of patients with idiopathic pulmonary fibrosis: results of a 3 year follow-up,” European Respiratory Journal, vol. 7, no. 4, pp. 643–650, 1994. View at Google Scholar · View at Scopus
  12. R. M. Cherniack, T. V. Colby, A. Flint et al., “Correlation of structure and function in idiopathic pulmonary fibrosis,” American Journal of Respiratory and Critical Care Medicine, vol. 151, no. 4, pp. 1180–1188, 1995. View at Google Scholar · View at Scopus
  13. A. Xaubet, C. Agustí, P. Luburich et al., “Pulmonary function tests and CT scan in the management of idiopathic pulmonary fibrosis,” American Journal of Respiratory and Critical Care Medicine, vol. 158, no. 2, pp. 431–436, 1998. View at Google Scholar · View at Scopus
  14. J. Stocks and P. H. Quanjer, “Reference values for residual volume, functional residual capacity and total lung capacity: ATS Workshop on Lung Volume Measurements Official Statement of the European Respiratory Society,” European Respiratory Journal, vol. 8, no. 3, pp. 492–506, 1995. View at Google Scholar · View at Scopus
  15. “Standardized lung function testing. Official statement of the European Respiratory Society,” The European Respiratory Journal. Supplement, vol. 16, pp. 1–100, 1993.
  16. R. Pellegrino, G. Viegi, V. Brusasco et al., “Interpretative strategies for lung function tests,” European Respiratory Journal, vol. 26, no. 5, pp. 948–968, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. “ATS statement: guidelines for the six-minute walk test,” American Journal of Respiratory and Critical Care Medicine, vol. 1, no. 166, pp. 111–117, 2002.
  18. V. N. Lama, K. R. Flaherty, G. B. Toews et al., “Prognostic value of desaturation during a 6 minute walk test in idiopathic interstitial pneumonia,” American Journal of Respiratory and Critical Care Medicine, vol. 168, no. 9, pp. 1084–1090, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Wallaert, C. Talleu, L. Wemeau-Stervinou, A. Duhamel, S. Robin, and B. Aguilaniu, “Reduction of maximal oxygen uptake in sarcoidosis: relationship with disease severity,” Respiration, vol. 82, pp. 501–508, 2011. View at Google Scholar
  20. C. A. Sorbini, V. Grassi, E. Solinas, and G. Muiesan, “Arterial oxygen tension in relation to age in healthy subjects,” Respiration, vol. 25, no. 1, pp. 3–13, 1968. View at Google Scholar · View at Scopus
  21. “ATS/ACCP Statement on cardiopulmonary exercise testing,” American Journal of Respiratory and Critical Care Medicine, vol. 167, pp. 211–277, 2003.
  22. C. Cooper and T. Storer, Exercise Testing and Interpretation. A Practical Approach, Cambridge, UK, 2001.
  23. N. L. Jones, Clinical Exercise Testing, WB Saunders, Philadelphia, Pa, USA, 1997.
  24. K. Wasserman, J. E. Hansen, D. Y. Sue, R. Casaburi, and B. J. Whipp, Principles of Exercise Testing and Interpretation, 3rd edition, 1999.
  25. B. Aguilaniu, R. Richard, F. Costes et al., “Cardiopulmonary exercise testing,” Revue des Maladies Respiratoires, vol. 24, no. 3, part 2, pp. 2S111–2S160, 2007. View at Google Scholar
  26. T. L. Dunn, L. C. Watters, C. Hendrix, R. M. Cherniack, M. I. Schwarz, and T. E. King, “Gas exchange at a given degree of volume restriction is different in sarcoidosis and idiopathic pulmonary fibrosis,” American Journal of Medicine, vol. 85, no. 2, pp. 221–224, 1988. View at Google Scholar · View at Scopus
  27. B. A. Keogh, E. Lakatos, D. Price, and R. G. Crystal, “Importance of the lower respiratory tract in oxygen transfer. Exercise testing in patients with interstitial and destructive lung disease,” American Review of Respiratory Disease, vol. 129, no. 2, pp. S76–S80, 1984. View at Google Scholar · View at Scopus
  28. R. Erbes, T. Schaberg, and R. Loddenkemper, “Lung function tests in patients with idiopathic pulmonary fibrosis: are they helpful for predicting outcome?” Chest, vol. 111, no. 1, pp. 51–57, 1997. View at Google Scholar · View at Scopus
  29. S. Nagai, M. Kitaichi, H. Itoh, K. Nishimura, T. Izumi, and T. V. Colby, “Idiopathic nonspecific interstitial pneumonia/fibrosis: comparison with idiopathic pulmonary fibrosis and BOOP,” European Respiratory Journal, vol. 12, no. 3, pp. 1010–1019, 1998. View at Google Scholar · View at Scopus
  30. J. A. Bjoraker, J. H. Ryu, M. K. Edwin et al., “Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis,” American Journal of Respiratory and Critical Care Medicine, vol. 157, no. 1, pp. 199–203, 1998. View at Google Scholar · View at Scopus
  31. Z. D. Daniil, F. C. Gilchrist, A. G. Nicholson et al., “A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis,” American Journal of Respiratory and Critical Care Medicine, vol. 160, no. 3, pp. 899–905, 1999. View at Google Scholar · View at Scopus
  32. A. G. Nicholson, T. V. Colby, R. M. Dubois, D. M. Hansell, and A. U. Wells, “The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis,” American Journal of Respiratory and Critical Care Medicine, vol. 162, no. 6, pp. 2213–2217, 2000. View at Google Scholar · View at Scopus
  33. N. Mogulkoc, M. H. Brutsche, P. W. Bishop, S. M. Greaves, A. W. Horrocks, and J. J. Egan, “Pulmonary function in idiopathic pulmonary fibrosis and referral for lung transplantation,” American Journal of Respiratory and Critical Care Medicine, vol. 164, no. 1, pp. 103–108, 2001. View at Google Scholar · View at Scopus
  34. P. I. Latsi, R. M. Du Bois, A. G. Nicholson et al., “Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends,” American Journal of Respiratory and Critical Care Medicine, vol. 168, no. 5, pp. 531–537, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. H. R. Collard, T. E. King, B. B. Bartelson, J. S. Vourlekis, M. I. Schwarz, and K. K. Brown, “Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis,” American Journal of Respiratory and Critical Care Medicine, vol. 168, no. 5, pp. 538–542, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. K. R. Flaherty, J. A. Mumford, S. Murray et al., “Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia,” American Journal of Respiratory and Critical Care Medicine, vol. 168, no. 5, pp. 543–548, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. Y. Jegal, S. K. Dong, S. S. Tae et al., “Physiology is a stronger predictor of survival than pathology in fibrotic interstitial pneumonia,” American Journal of Respiratory and Critical Care Medicine, vol. 171, no. 6, pp. 639–644, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. E. A. Gaensler and C. B. Carrington, “Open biopsy for chronic diffuse infiltrative lung disease: clinical, roentgenographic, and physiological correlations in 502 patients,” The Annals of Thoracic Surgery, vol. 30, no. 5, pp. 411–426, 1980. View at Publisher · View at Google Scholar
  39. R. G. Crystal, J. D. Fulmer, W. C. Roberts, M. L. Moss, B. R. Line, and H. Y. Reynolds, “Idiopathic pulmonary fibrosis. Clinical, histologic, radiographic, physiologic, scintigraphic, cytologic, and biochemical aspects,” Annals of Internal Medicine, vol. 85, no. 6, pp. 769–788, 1976. View at Google Scholar
  40. A. Miller, L. K. Brown, M. F. Sloane, A. Bhuptani, and A. S. Teirstein, “Cardiorespiratory responses to incremental exercise in sarcoidosis patients with normal spirometry,” Chest, vol. 107, no. 2, pp. 323–329, 1995. View at Google Scholar · View at Scopus
  41. M. Karetzky and M. McDonough, “Exercise and resting pulmonary function in sarcoidosis,” Sarcoidosis Vasculitis and Diffuse Lung Disease, vol. 13, no. 1, pp. 43–49, 1996. View at Google Scholar · View at Scopus
  42. E. H. Elpern, D. Stevens, and S. Kesten, “Variability in performance of timed walk tests in pulmonary rehabilitation programs,” Chest, vol. 118, no. 1, pp. 98–105, 2000. View at Google Scholar · View at Scopus
  43. L. Wémeau-Stervinou, T. Perez, C. Murphy, A.-S. Polge, and B. Wallaert, “Lung capillary blood volume and membrane diffusion in idiopathic interstitial pneumonia,” Respiratory Medicine, vol. 106, pp. 564–570, 2012. View at Google Scholar
  44. T. E. King Jr., S. Safrin, K. M. Starko et al., “Analyses of efficacy end points in a controlled trial of interferon-γ1b for idiopathic pulmonary fibrosis,” Chest, vol. 127, no. 1, pp. 171–177, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. D. A. Lynch, J. D. Godwin, S. Safrin et al., “High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis,” American Journal of Respiratory and Critical Care Medicine, vol. 172, no. 4, pp. 488–493, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. G. Raghu, K. K. Brown, W. Z. Bradford et al., “A placebo-controlled trial of interferon Gamma-1b in patients with idiopathic pulmonary fibrosis,” The New England Journal of Medicine, vol. 350, no. 2, pp. 125–133, 2004. View at Publisher · View at Google Scholar · View at Scopus